US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
AU3216695A
(en)
*
|
1994-08-29 |
1996-03-22 |
University Of North Carolina At Chapel Hill, The |
Lipid analogs for treating viral infections
|
UA72558C2
(uk)
*
|
1999-11-01 |
2005-03-15 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
1-аміноалкілциклогексанові антагоністи рецептора nmda
|
US6444702B1
(en)
|
2000-02-22 |
2002-09-03 |
Neuromolecular, Inc. |
Aminoadamantane derivatives as therapeutic agents
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
NZ547204A
(en)
|
2000-05-26 |
2008-01-31 |
Idenix Cayman Ltd |
Methods and compositions for treating flaviviruses and pestiviruses
|
TW593223B
(en)
*
|
2000-06-20 |
2004-06-21 |
Merz Pharma Gmbh & Co Kgaa |
1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
|
US6602862B1
(en)
*
|
2000-09-19 |
2003-08-05 |
Merz Pharma Gmbh & Co., Kgaa |
1-Amino-alkylcyclohexanes as trypanocidal agents
|
CN1646141B
(zh)
|
2000-10-18 |
2014-06-25 |
吉利德制药有限责任公司 |
用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物
|
WO2002044717A1
(en)
*
|
2000-12-01 |
2002-06-06 |
Cornell Research Foundation |
Animal model for flaviviridae infection
|
AU2002232660A1
(en)
*
|
2000-12-15 |
2002-06-24 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
US7375136B2
(en)
*
|
2001-03-08 |
2008-05-20 |
Emory University |
pH-dependent NMDA receptor antagonists
|
AU2002330154A1
(en)
*
|
2001-09-28 |
2003-04-07 |
Centre National De La Recherche Scientifique |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
US6828462B2
(en)
*
|
2001-11-07 |
2004-12-07 |
Merz Pharma Gmbh & Co. Kgaa |
Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
|
JP2005522443A
(ja)
*
|
2002-02-14 |
2005-07-28 |
フアーマセツト・リミテツド |
改変フッ素化ヌクレオシド類似体
|
WO2004002999A2
(en)
|
2002-06-28 |
2004-01-08 |
Idenix (Cayman) Limited |
Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
|
AU2003251993A1
(en)
*
|
2002-07-19 |
2004-02-09 |
Inge Grundke-Iqbal |
NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau
|
CA2494340C
(en)
*
|
2002-08-01 |
2012-01-24 |
Pharmasset Inc. |
Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections
|
GEP20094759B
(en)
|
2002-10-24 |
2009-08-25 |
Merz Pharma Gmbh & Co Kgaa |
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
|
KR20050088079A
(ko)
|
2002-11-15 |
2005-09-01 |
이데닉스 (케이만) 리미티드 |
2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
RS20050851A
(sr)
*
|
2003-05-27 |
2008-04-04 |
Forest Laboratories Inc., |
Kombinacija antagonista nmda receptora i selektivnog inhibitora ponovnog preuzimanja serotonina za lečenje depresije i drugih poremećaja raspoloženja
|
CA2734052A1
(en)
|
2003-05-30 |
2005-01-13 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
PL1658302T3
(pl)
|
2003-07-25 |
2011-03-31 |
Idenix Pharmaceuticals Inc |
Analogi nukleozydów purynowych do leczenia chorób spowodowanych przez Flaviviridae obejmujących zapalenie wątroby typu C
|
CA2529674A1
(en)
*
|
2003-07-28 |
2005-02-03 |
Merz Pharma Gmbh & Co. Kgaa |
The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity
|
US20050113458A1
(en)
*
|
2003-10-22 |
2005-05-26 |
Forest Laboratories, Inc. |
Use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic a-beta peptides in amyloidopathies
|
AR046314A1
(es)
|
2003-11-05 |
2005-11-30 |
Merz Pharma Gmbh & Co Kgaa |
Composiciones que comprenden ciclohexilaminas y aminoadamantanos
|
UY28650A1
(es)
*
|
2003-12-05 |
2005-02-28 |
Forest Laboratories |
Memantina para la prevencion o disminucion de la conducta suicida y para el tratamiento de la depresion mayor asociada con esta conducta
|
GB0500020D0
(en)
|
2005-01-04 |
2005-02-09 |
Novartis Ag |
Organic compounds
|
RU2371173C2
(ru)
*
|
2004-01-05 |
2009-10-27 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
Мемантин для лечения болезни альцгеймера легкой и от легкой до умеренной степени тяжести
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
TW200531680A
(en)
*
|
2004-03-03 |
2005-10-01 |
Merz Pharma Gmbh & Co Kgaa |
Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
|
US20060002999A1
(en)
*
|
2004-06-17 |
2006-01-05 |
Forest Laboratories, Inc. |
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
|
CN101389315A
(zh)
|
2004-06-17 |
2009-03-18 |
莫茨药物股份两合公司 |
美金刚口服剂型即释制剂
|
US8039009B2
(en)
*
|
2004-06-17 |
2011-10-18 |
Forest Laboratories Holdings Limited |
Modified release formulations of memantine oral dosage forms
|
CA2571675A1
(en)
*
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
RU2433124C2
(ru)
*
|
2004-09-14 |
2011-11-10 |
Фармассет, Инк. |
Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
|
TW200621677A
(en)
*
|
2004-09-21 |
2006-07-01 |
Astellas Pharma Inc |
Cyclic amine derivative or salt thereof
|
US20060205822A1
(en)
*
|
2004-12-22 |
2006-09-14 |
Forest Laboratories, Inc. |
1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
|
WO2006138227A1
(en)
*
|
2005-06-16 |
2006-12-28 |
Forest Laboratories, Inc. |
Modified and immediate release memantine bead formulation
|
US20070099947A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Alkermes, Inc. |
Methods and compositions for the treatment of brain reward system disorders by combination therapy
|
US20070141148A1
(en)
*
|
2005-11-30 |
2007-06-21 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane MR matrix tablet
|
CA2643680A1
(en)
|
2006-04-11 |
2007-11-22 |
Novartis Ag |
Hcv/hiv inhibitors and their uses
|
WO2008005534A2
(en)
*
|
2006-07-06 |
2008-01-10 |
Forest Laboratories, Inc. |
Orally dissolving formulations of memantine
|
SI2042480T1
(sl)
|
2006-07-18 |
2013-08-30 |
Astellas Pharma Inc. |
Aminoindanski derivati ali njegova sol
|
TW200823215A
(en)
|
2006-08-04 |
2008-06-01 |
Merz Pharma Gmbh & Amp Co Kgaa |
Pyrazolopyrimidines, a process for their preparation and the use as a medicine
|
WO2008055945A1
(en)
|
2006-11-09 |
2008-05-15 |
Probiodrug Ag |
3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
|
US9126987B2
(en)
|
2006-11-30 |
2015-09-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
PT2144604E
(pt)
|
2007-02-28 |
2011-10-19 |
Conatus Pharmaceuticals Inc |
Métodos para o tratamento da hepatite c viral crónica utilizando ro-113-0830
|
CN101668525A
(zh)
|
2007-03-01 |
2010-03-10 |
前体生物药物股份公司 |
谷氨酰胺酰环化酶抑制剂的新用途
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
EP2142514B1
(de)
|
2007-04-18 |
2014-12-24 |
Probiodrug AG |
Thioharnstoffderivate als glutaminylcyclaseinhibitoren
|
TW200916091A
(en)
*
|
2007-06-08 |
2009-04-16 |
Merz Pharma Gmbh & Amp Co Kgaa |
Neramexane for the treatment of nystagmus
|
AU2008272964A1
(en)
*
|
2007-06-29 |
2009-01-08 |
Emory University |
NMDA receptor antagonists for neuroprotection
|
EP2018854A1
(de)
*
|
2007-07-27 |
2009-01-28 |
Merz Pharma GmbH & Co. KGaA |
Neuartige Kombination von Neramexan zur Behandlung neurodegenerativer Erkrankungen
|
RU2446794C2
(ru)
*
|
2007-09-12 |
2012-04-10 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
Терапия с интервалами для лечения тиннитуса
|
CN101801365A
(zh)
*
|
2007-09-12 |
2010-08-11 |
莫茨药物股份两合公司 |
治疗耳鸣的间隔疗法
|
EP2085398A1
(de)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidine, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel
|
EP2090576A1
(de)
|
2008-02-01 |
2009-08-19 |
Merz Pharma GmbH & Co.KGaA |
6-halo-Pyrazolo[1,5-a]pyridin-Verbindungen, Verfahren zu ihrer Herstellung und Verwendung als Modulatoren des Metabotropen Glutamatrezeptoren (mGluR)
|
TW200946541A
(en)
*
|
2008-03-27 |
2009-11-16 |
Idenix Pharmaceuticals Inc |
Solid forms of an anti-HIV phosphoindole compound
|
WO2009151498A2
(en)
*
|
2008-03-28 |
2009-12-17 |
Forest Laboratories Holdings Limited |
Memantine formulations
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
EP2111858A1
(de)
|
2008-04-25 |
2009-10-28 |
EPFL Ecole Polytechnique Fédérale de Lausanne |
Neue Behandlung für Morbus Alzheimer
|
US20090275597A1
(en)
*
|
2008-05-02 |
2009-11-05 |
Forest Laboratories Holdings Limited |
Methods of treating cns disorders
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
TW201010691A
(en)
*
|
2008-06-12 |
2010-03-16 |
Merz Pharma Gmbh & Co Kgaa |
1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
|
TW201006463A
(en)
*
|
2008-06-26 |
2010-02-16 |
Merz Pharma Gmbh & Co Kgaa |
Pharmaceutical compositions comprising aminocyclohexane derivatives
|
BRPI0913677A2
(pt)
|
2008-07-02 |
2015-12-15 |
Idenix Pharmaceuticals Inc |
composto, metabólito purificado, método para tratar um hospedeiro infectado com um vírus flaviviridade, composição farmacêutica, método para preparar o composto purificado, e, processo para preparar o composto
|
UA105182C2
(ru)
|
2008-07-03 |
2014-04-25 |
Ньюрексон, Інк. |
Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
|
TWI432188B
(zh)
|
2008-12-19 |
2014-04-01 |
Merz Pharma Gmbh & Co Kgaa |
供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類
|
US8399519B2
(en)
*
|
2008-12-19 |
2013-03-19 |
Merz Pharma Gmbh & Co. Kgaa |
1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
|
EA201100851A1
(ru)
|
2008-12-23 |
2012-04-30 |
Фармассет, Инк. |
Аналоги нуклеозидов
|
CL2009002206A1
(es)
|
2008-12-23 |
2011-08-26 |
Gilead Pharmasset Llc |
Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
|
NZ593648A
(en)
|
2008-12-23 |
2013-09-27 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
JP5690286B2
(ja)
|
2009-03-04 |
2015-03-25 |
イデニク プハルマセウティカルス,インコーポレイテッド |
ホスホチオフェン及びホスホチアゾールhcvポリメラーゼ阻害剤
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
BRPI1011322A2
(pt)
*
|
2009-04-17 |
2018-09-18 |
Merz Pharma Gmbh & Co Kgaa |
1-amino-1,3,3,5,5-pentametilciclohexano mesilato, seu processo de fabricação, suas partículas e seus cristais, uso de anisol ou uma mistura de anisol e pelo menos um dos solventes, e composição farmacêutica.
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
WO2011000537A1
(en)
|
2009-06-29 |
2011-01-06 |
Merz Pharma Gmbh & Co. Kgaa |
Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane
|
BRPI1012669A2
(pt)
*
|
2009-06-29 |
2016-04-05 |
Merz Pharma Gmbh & Co Kgaa |
metodo de preparacao de 3,3,5,5-tetrametliciclohexanona, método de preparção de 1-amino-1,3,3,5,5,-pentametilciclohexano ou um sal farmaceuticamente aceitável do mesmo e composto
|
WO2011000536A1
(en)
|
2009-06-29 |
2011-01-06 |
Merz Pharma Gmbh & Co. Kgaa |
Method of preparing 1-hydroxy-1,3,3,5,5-pentamethylcyclohexane
|
WO2011017389A1
(en)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
TW201116532A
(en)
|
2009-08-05 |
2011-05-16 |
Merz Pharma Gmbh & Co Kgaa |
Metabotropic glutamate receptor modulators
|
SG178953A1
(en)
|
2009-09-11 |
2012-04-27 |
Probiodrug Ag |
Heterocylcic derivatives as inhibitors of glutaminyl cyclase
|
WO2011035924A1
(en)
*
|
2009-09-28 |
2011-03-31 |
Merz Pharma Gmbh & Co. Kgaa |
Method of preparing neramexane or a salt thereof
|
WO2011063076A1
(en)
|
2009-11-19 |
2011-05-26 |
Itherx Pharmaceuticals, Inc. |
Methods of treating hepatitis c virus with oxoacetamide compounds
|
MY159958A
(en)
|
2009-12-18 |
2017-02-15 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
ES2586231T3
(es)
|
2010-03-03 |
2016-10-13 |
Probiodrug Ag |
Inhibidores de glutaminil ciclasa
|
DK2545047T3
(da)
|
2010-03-10 |
2014-07-28 |
Probiodrug Ag |
Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
BR112012024884A2
(pt)
|
2010-03-31 |
2016-10-18 |
Gilead Pharmasset Llc |
síntese estereosseletiva de ativos contendo fósforo
|
MX2012011222A
(es)
|
2010-04-01 |
2013-01-18 |
Centre Nat Rech Scient |
Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
|
WO2011131748A2
(en)
|
2010-04-21 |
2011-10-27 |
Probiodrug Ag |
Novel inhibitors
|
US20110294890A1
(en)
|
2010-05-28 |
2011-12-01 |
Merz Pharma Gmbh & Co. Kgaa |
Neramexane for the treatment or prevention of inner ear disorders
|
CA2797320A1
(en)
*
|
2010-06-18 |
2011-12-22 |
Merz Pharma Gmbh & Co. Kgaa |
Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives
|
US9011833B2
(en)
|
2010-10-08 |
2015-04-21 |
Novartis Ag |
Vitamin E formulations of sulfamide NS3 inhibitors
|
WO2012048871A1
(en)
|
2010-10-12 |
2012-04-19 |
Merz Pharma Gmbh & Co. Kgaa |
Memantine for improving cognitive performance in subjects
|
AR084044A1
(es)
|
2010-11-30 |
2013-04-17 |
Pharmasset Inc |
Compuestos 2’-espiro-nucleosidos
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
JP6084931B2
(ja)
|
2011-01-20 |
2017-02-22 |
メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン |
ストレス又は急性聴力損失に関連する耳鳴の治療又は予防のためのネラメキサン
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
WO2012107584A1
(en)
|
2011-02-11 |
2012-08-16 |
Universite Pierre Et Marie Curie (Paris 6) |
Methods for predicting outcome of a hepatitis virus infection
|
ES2570167T3
(es)
|
2011-03-16 |
2016-05-17 |
Probiodrug Ag |
Derivados de benzimidazol como inhibidores de glutaminil ciclasa
|
WO2012154321A1
(en)
|
2011-03-31 |
2012-11-15 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
KR20140063657A
(ko)
|
2011-08-03 |
2014-05-27 |
사이세리스 |
Hcv 면역요법
|
AU2012308900A1
(en)
|
2011-09-12 |
2013-05-09 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
WO2013039920A1
(en)
|
2011-09-12 |
2013-03-21 |
Idenix Pharmaceuticals, Inc. |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
EP2768838A1
(de)
|
2011-10-14 |
2014-08-27 |
IDENIX Pharmaceuticals, Inc. |
Substituierte 3 ', 5 '-cyclophosphate von purin-nukleotid-verbindungen und pharmazeutische zusammensetzungen für die behandlung von virusinfektionen
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
US9089574B2
(en)
|
2011-11-30 |
2015-07-28 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
US8809354B2
(en)
|
2011-12-31 |
2014-08-19 |
Sheikh Riazuddin |
3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
|
US20130217644A1
(en)
|
2012-02-13 |
2013-08-22 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate]
|
EP2852605B1
(de)
|
2012-05-22 |
2018-01-31 |
Idenix Pharmaceuticals LLC |
3',5'-cyclische phosphat-prodrugs für hcv-infektion
|
AP3913A
(en)
|
2012-05-22 |
2016-11-26 |
Idenix Pharamaceuticals Inc |
D-amino acid compounds for liver disease
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
RU2488388C1
(ru)
*
|
2012-05-24 |
2013-07-27 |
Ооо "Валента Интеллект" |
Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств
|
UA107653U
(uk)
|
2012-10-01 |
2016-06-24 |
Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" |
Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
|
PE20151318A1
(es)
|
2012-10-08 |
2015-10-03 |
Idenix Pharmaceuticals Inc |
Analogos de 2'-cloro nucleosido para infeccion por vhc
|
WO2014063019A1
(en)
|
2012-10-19 |
2014-04-24 |
Idenix Pharmaceuticals, Inc. |
Dinucleotide compounds for hcv infection
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
WO2014078436A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of sp-nucleoside analog
|
US20140140951A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-Alanine Ester of Rp-Nucleoside Analog
|
EP2935304A1
(de)
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluor-nukleoside zur behandlung von hcv
|
WO2014137926A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
3'-deoxy nucleosides for the treatment of hcv
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
EP3004130B1
(de)
|
2013-06-05 |
2019-08-07 |
Idenix Pharmaceuticals LLC. |
1',4'-thionukleoside zur behandlung von hcv
|
WO2015017713A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
ES2792503T3
(es)
|
2013-08-27 |
2020-11-11 |
Gilead Pharmasset Llc |
Formulación combinada de dos compuestos antivirales
|
EP3046924A1
(de)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Inhibitoren des hepatitis-c-virus
|
WO2015061683A1
(en)
|
2013-10-25 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv
|
EP3063165A1
(de)
|
2013-11-01 |
2016-09-07 |
Idenix Pharmaceuticals LLC |
D-alanin-phosphoramidat-pronukleotide von 2'-methyl-2'-fluor-guanosin-nukleosid-verbindungen zur behandlung von hcv
|
US20170198005A1
(en)
|
2013-11-27 |
2017-07-13 |
Idenix Pharmaceuticals Llc |
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
|
EP3083654A1
(de)
|
2013-12-18 |
2016-10-26 |
Idenix Pharmaceuticals LLC |
4'-or-nukleoside zur behandlung von hcv
|
US20170135990A1
(en)
|
2014-03-05 |
2017-05-18 |
Idenix Pharmaceuticals Llc |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
EP3131914B1
(de)
|
2014-04-16 |
2023-05-10 |
Idenix Pharmaceuticals LLC |
3'-substituierte methyl- oder alkynylnukleoside zur behandlung von hcv
|
KR102672910B1
(ko)
*
|
2017-01-10 |
2024-06-07 |
오웬-배리 파머소티컬즈 인코포레이티드 |
항경련 화합물
|
PL3461819T3
(pl)
|
2017-09-29 |
2020-11-30 |
Probiodrug Ag |
Inhibitory cyklazy glutaminylowej
|
WO2023154014A1
(en)
|
2022-02-08 |
2023-08-17 |
Sahin Fikret |
Nmdar antagonists prevent ageing and aging-associated conditions and diseases through increasing 20s proteasome activity
|